BE621398A - - Google Patents
Info
- Publication number
- BE621398A BE621398A BE621398DA BE621398A BE 621398 A BE621398 A BE 621398A BE 621398D A BE621398D A BE 621398DA BE 621398 A BE621398 A BE 621398A
- Authority
- BE
- Belgium
- Prior art keywords
- sugar
- viruses
- cores
- candy
- desc
- Prior art date
Links
- 235000009508 confectionery Nutrition 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 241000991587 Enterovirus C Species 0.000 description 9
- 208000000474 Poliomyelitis Diseases 0.000 description 8
- 229960005486 vaccines Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 230000002238 attenuated Effects 0.000 description 5
- 241000274177 Juniperus sabina Species 0.000 description 4
- 210000004940 Nucleus Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- HDAJUGGARUFROU-UHFFFAOYSA-L ({5-amino-7,13,13-trioxo-17-oxa-12,14-dithia-2,4,6,9-tetraaza-13-molybdatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-3(8),4,11(15)-trien-16-yl}methoxy)phosphonic acid Chemical compound O=[Mo+2]=O.N1C(C(=C([S-])C(COP(O)(O)=O)O2)[S-])C2NC2=C1C(=O)N=C(N)N2 HDAJUGGARUFROU-UHFFFAOYSA-L 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N Alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282619 Hylobates lar Species 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 229940035295 Ting Drugs 0.000 description 1
- 241001459538 Ute Species 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 125000003607 serino group Chemical class [H]OC(=O)C([H])(N([H])*)C([H])([H])O[H] 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE621398A true BE621398A (ja) | 1900-01-01 |
Family
ID=194439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE621398D BE621398A (ja) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE621398A (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0420785A2 (en) * | 1989-09-29 | 1991-04-03 | The Nisshin Oil Mills, Ltd. | Stable immunogen composition |
| EP0603992A1 (en) * | 1992-12-22 | 1994-06-29 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
-
0
- BE BE621398D patent/BE621398A/fr unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0420785A2 (en) * | 1989-09-29 | 1991-04-03 | The Nisshin Oil Mills, Ltd. | Stable immunogen composition |
| EP0420785A3 (en) * | 1989-09-29 | 1991-07-31 | Nisshin Oil Mills Ltd | Stable immunogen composition |
| US5176909A (en) * | 1989-09-29 | 1993-01-05 | The Nisshin Oil Mills, Ltd. | Stable immunogen composition for oral administration |
| US5591433A (en) * | 1991-06-21 | 1997-01-07 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
| EP0603992A1 (en) * | 1992-12-22 | 1994-06-29 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
| EP0603992B1 (en) * | 1992-12-22 | 1996-10-09 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6616431B2 (ja) | マイクロバイオータ回復治療（ｍｒｔ）組成物の製造方法 | |
| US10828340B2 (en) | Microbiota restoration therapy (MRT) compositions and methods of manufacture | |
| MX2008014398A (es) | Formulacion de vacuna de nicotina-portador. | |
| JPH06509547A (ja) | リポソーム−ポリエンプレリポソーム粉末とその製造方法 | |
| CN112566649A (zh) | 微生物群恢复治疗(mrt)组合物和制造方法 | |
| BE621398A (ja) | ||
| JP2017186346A (ja) | 液状生物学的活性成分の固形製剤を含む非静脈内剤型およびその使用 | |
| CN108938675B (zh) | 一种粪菌定位移植方法 | |
| Pu et al. | Salting-Out crystallization of glycopeptide Vancomycin: Phase behavior study to control the crystal habit | |
| ES2314772T3 (es) | Composicion para la prevencion y tratamiento de afecciones catarrales. | |
| US9616125B2 (en) | Stable nocathiacin lyophilized injection agent | |
| Pardeshi et al. | Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review | |
| TW200526268A (en) | Injectable composition | |
| EP0278877B1 (fr) | Formes galéniques d'allergènes pour administration par voie sublinguale | |
| RU2225709C2 (ru) | Лиофилизат с улучшенной восстанавливаемостью в исходное состояние (варианты), способ его получения и фармацевтический препарат | |
| TWI684451B (zh) | 水飛薊賓注射劑及其製備方法 | |
| CN107011419A (zh) | 具有抗病毒活性的板蓝根活性糖肽及其制备方法与应用 | |
| CA1328600C (fr) | Compositions medicamenteuses a base d'oeufs de caille | |
| BE1005589A3 (fr) | Medicament pour le traitement de la dermatite. | |
| KR102540346B1 (ko) | 꿀벌 유인용 조성물 및 이를 포함하는 양봉용 약물 전달 시스템 | |
| CN105997868B (zh) | 一种达比加群酯纳米混合胶束及其制备方法 | |
| EP1341555A2 (fr) | Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation | |
| FR2479690A1 (fr) | Medicament utile notamment pour le traitement de l'arthrite et son procede d'obtention par extraction des feuilles et rhizomes de polypodiaceae | |
| CN107998111A (zh) | DAS在制备预防/或治疗LPS/D-GalN诱导的急性免疫性肝损伤药物中的应用 | |
| WO2020143333A1 (zh) | 蒲公英甾酮在制备防治老年痴呆的药物中的应用 |